China Pharma Holdings Inc (CPHI) — Cash Flow Reinvestment Rate
China Pharma Holdings Inc (CPHI) has a Cash Flow Reinvestment Rate of 0.07x as of June 2025, reinvesting $19.84K (capex $9.92K plus investments $-9.92K) from operating cash flow of $291.08K. Check China Pharma Holdings Inc (CPHI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Pharma Holdings Inc Cash Flow Reinvestment Rate (2007–2019)
Historical reinvestment intensity for China Pharma Holdings Inc across 13 annual periods. Explore CPHI operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for China Pharma Holdings Inc (2007–2019)
Year-by-year capital reinvestment analysis for China Pharma Holdings Inc. For live market cap and broader valuation context, see CPHI market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.45x | $272.01K | $608.31K | $136.00K | ▲ +449.5% |
| 2018 | 0.08x | $102.29K | $1.26 Million | $51.15K | ▼ -74.9% |
| 2017 | 0.32x | $272.96K | $841.22K | $136.48K | ▲ +142.9% |
| 2016 | 0.13x | $386.81K | $2.90 Million | $193.40K | ▼ -80.7% |
| 2015 | 0.69x | $2.32 Million | $3.35 Million | $2.32 Million | ▼ -45.8% |
| 2014 | 1.28x | $5.84 Million | $4.57 Million | $5.84 Million | ▼ -42.5% |
| 2013 | 2.22x | $19.09 Million | $8.60 Million | $19.09 Million | ▲ +62.3% |
| 2012 | 1.37x | $4.99 Million | $3.64 Million | $4.99 Million | ▲ +29.3% |
| 2011 | 1.06x | $5.54 Million | $5.24 Million | $5.54 Million | ▼ -21.7% |
| 2010 | 1.35x | $10.52 Million | $7.79 Million | $10.52 Million | ▼ -6.2% |
| 2009 | 1.44x | $15.36 Million | $10.67 Million | $15.36 Million | ▲ +10.9% |
| 2008 | 1.30x | $8.49 Million | $6.54 Million | $8.49 Million | ▲ +21.7% |
| 2007 | 1.07x | $2.99 Million | $2.80 Million | $2.99 Million | — |